The origin, function, and diagnostic potential of RNA within extracellular vesicles present in human biological fluids

Frontiers in Genetics

Volumn 4, Issue JUL, 2013, Pages

  Taylor, Douglas D ^a   Gercel Taylor, Cicek ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Early diagnosis; Exosomes; MicroRNA; Microvesicles; Transcriptome

Indexed keywords

EID: 84883548848     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2013.00142     Document Type: Review

References (96)

1. Abusamra, A. J., Zhong, Z., and Zheng, X. (2005). Tumor exosomes expressing Fas ligand mediate CD8+ T-cell apoptosis. Blood Cells Mol. Dis. 35, 169-173. doi: 10.1016/j.bcmd.2005.07.001
2. Admyre, C., Telemo, E., Almqvist, N., Lotvall, J., Lahesmaa, R., Scheynius, A., et al. (2008). Exosomes-nanovesicles with possible roles in allergy inflammation. Allergy 63, 404-408. doi: 10.1111/j.1398-9995.2007.01600.x
3. Al-Nedawi, K., Meehan, B., Micallef, J., Lhotak, V., May, L., Guha, A., et al. (2008). Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat. Cell Biol. 10, 619-624. doi: 10.1038/ncb1725
4. Al-Nedawi, K., Meehan, B., and Rak, J. (2009a). Microvesicles: messengers and mediators of tumor progression. Cell Cycle 8, 2014-2018. doi: 10.4161/cc.8.13.8988
5. Al-Nedawi, K., Meehan, B., Kerbel, R. S., Allison, A. C., and Rak, J. (2009b). Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR. Proc. Natl. Acad. Sci. U.S.A. 106, 3794-3799. doi: 10.1073/pnas.0804543106
6. Anand, P. K. (2010). Exosomal membrane molecules are potent immune response modulators. Commun. Integr. Biol. 3, 405-408. doi: 10.4161/cib.3.5.12474
7. Ashiru, O., Boutet, P., and Fernandez-Messina, L. (2010). Natural killer cell cytotoxicity is suppressed by exposure to the human NKG2D ligand MICA+008 that is shed by tumor cells in exosomes. Cancer Res. 70, 481. doi: 10.1158/0008-5472.CAN-09-1688
8. Atay, S., Gercel-Taylor, C., Kesimer, M., and Taylor, D. D. (2011a). Morphologic and proteomic characterization of exosomes released by cultured extravillous trophoblast cells. Exp. Cell Res. 317, 1192-1202. doi: 10.1016/j.yexcr.2011.01.014
9. Atay, S., Gercel-Taylor, C., and Taylor, D. D. (2011b). Human trophoblast-derived exosomal fibronectin induces pro-inflammatory IL-1?? production by macrophages. Am. J. Reprod. Immunol. 66, 259-269. doi: 10.1111/j.1600-0897.2011.00995.x
10. Atay, S., Roberson, C., Gercel-Taylor, C., and Taylor, D. D. (2013). Ovarian cancer patient-derived exosomal fibronectin induces pro-inflammatory il-1?? production by macrophages. Exos. Microves. 1, 1. doi: 10.5772/56180
11. Brouckova, A., and Holada, K. (2009). Cellular prion protein in blood platelets associates with both lipid rafts and the cytoskeleton. Thromb. Haemost. 102, 966-974.
12. Bryant, R. J., Pawlowski, T., Catto, J. W., Marsden, G., Vessella, R. L., Rhees, B., et al. (2012). Changes in circulating microRNA levels associated with prostate cancer. Br. J. Cancer 106, 768-774. doi: 10.1038/bjc.2011.595
13. Camussi, G., Deregibus, M. C., Bruno, S., Cantaluppi, V., and Biancone, L. (2010). Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int. 78, 838-848. doi: 10.1038/ki.2010.278
14. Chen, X., Liang, H., Zhang, J., Zen, K., and Zhang, C. Y. (2012). Horizontal transfer of microRNAs: molecular mechanisms and clinical applications. Protein Cell 3, 28-37. doi: 10.1007/s13238-012-2003-z
15. Cheng, J., Deng, H., Xiao, B., Zhou, H., Zhou, F., Shen, Z., et al. (2012). piR-823, a novel non-coding small RNA, demonstrates in vitro and in vivo tumor suppressive activity in human gastric cancer cells. Cancer Lett. 315, 12-17. doi: 10.1016/j.canlet.2011.10.004
16. Cheng, J., Guo, J. M., Xiao, B. X., Miao, Y., Jiang, Z., Zhou, H., et al. (2011). piRNA, the new non-coding RNA, is aberrantly expressed in human cancer cells. Clin. Chim. Acta. 412, 1621-1625. doi: 10.1016/j.cca.2011.05.015
17. Chinni, S. R., Gercel-Taylor, C., Falchetto, R. A., Shabanowitz, J., Hunt, D. F., and Taylor, D. D. (1997). Cathepsin D and glucose-regulated protein 78 recognized by the humoral response of ovarian cancer patients. Clin. Cancer Res. 3, 1557-1564.
18. Corrado, C., Raimondo, S., Chiesi, A., Ciccia, F., De Leo, G., and Alessandro, R. (2013). Exosomes as intercellular signaling organelles involved in health and disease: basic science and clinical applications. Int. J. Mol. Sci. 14, 5338-5366. doi: 10.3390/ijms14035338
19. Dolo, V., D'Ascenzo, S., Violini, S., Pompucci, L., Festuccia, C., Ginestra, A., et al. (1999a). Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro. Clin. Exp. Metastasis 17, 131-140. doi: 10.1023/A:1006500406240
20. Dolo, V., Ginestra, A., Cassara, D., Ghersi, G., Nagase, H., and Vittorelli, M. L. (1999b). Shed membrane vesicles and selective localization of gelatinases and MMP- 9/TIMP-1 complexes, Ann. N.Y. Acad. Sci. 878, 497-499. doi: 10.1111/j.1749-6632.1999.tb07707.x
21. Doring, T., Gotthardt, K., Stieler, J., and Prange, R. (2010). ??2-Adaptin is functioning in the late endosomal sorting pathway and interacts with ESCRT-I and -III subunits. Biochim. Biophys. Acta 1803, 1252-1264. doi: 10.1016/j.bbamcr.2010.08.001
22. Dubyak, G. R. (2012). P2X7 receptor regulation of non-classical secretion from immune effector cells. Cell. Microbiol. 14, 1697-1706. doi: 10.1111/cmi.12001
23. Duggagupta, R., Jiang, R., Gollub, J., Getts, R. C., and Jones, K. W. (2011). Impact of cellular miRNAs on circulating miRNA biomarker signatures. PLoS ONE 6:e20769. doi: 10.1371/journal.pone.0020769
24. El-Andaloussi, S., Lee, Y., Lakhal-Littleton, S., Li, J., Seow, Y., Gardiner, C., et al. (2012). Exosome-mediated delivery of siRNA in vitro and in vivo. Nat. Protoc. 7, 2112-2126. doi: 10.1038/nprot.2012.131
25. Gallo, A., Tandon, M., Alevizos, I., and Illei, G. G. (2012). The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS ONE 7, e30679. doi: 10.1371/journal.pone.0030679
26. Gercel-Taylor, C., Kesterson, S., and Taylor, D. D. (2013). Selective processing of miRNA in ovarian cancer cells. Exos. Microves. 1. (in press).
27. Gercel-Taylor, C., Tullis, R. H., Atay, S., Kesimer, M., and Taylor, D. D. (2012). Nanoparticle analysis of circulating cell-derived vesicles in ovarian cancer patients. Anal. Biochem. 428, 44-53. doi: 10.1016/j.ab.2012.06.004
28. Graner, M. W., Alzate, O., Dechkovskaia, A. M., Keene, J. D., Sampson, J. H., Mitchell, D. A., et al. (2009). Proteomic and immunologic analyses of brain tumor exosomes. FASEB J. 23, 1541-1557. doi: 10.1096/fj.08-122184
29. Grange, C., Tapparo, M., Collino, F., Vitillo, L., Damasco, C., Deregibus, M. C., et al. (2011). Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche. Cancer Res. 71, 5346-5356. doi: 10.1158/0008-5472.CAN-11-0241
30. Graves, L. E., Ariztia, E. V., Navari, J. R., Matzel, H. J., Stack, M. S., and Fishman, D. A. (2004). Proinvasive properties of ovarian cancer ascites-derived membrane vesicles. Cancer Res. 64, 7045-7049. doi: 10.1158/0008-5472.CAN-04-1800
31. Gutiérrez-Vázquez, C., Villarroya-Beltri, C., Mittelbrunn, M., and Sánchez-Madrid, F. (2013). Transfer of extracellular vesicles during immune cell-cell interactions. Immunol. Rev. 251, 125-142. doi: 10.1111/imr.12013
32. Harding, C., Heuser, J., and Stahl, P. (1983). Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes. J. Cell Biol. 97, 329-339. doi: 10.1083/jcb.97.2.329
33. Hong, B. S., Cho, J. H., Kim, H., Choi, E. J., Rho, S., Kim, J., et al. (2009). Colorectal cancer cell-derived microvesicles are enriched in cell cycle-related mRNAs that promote proliferation of endothelial cells. BMC Genomics 10, 556. doi: 10.1186/1471-2164-10-556
34. Ichim, T. E., Zhong, Z., Kaushal, S., Zheng, X., Ren, X., Hao, X., et al. (2008). Exosomes as a tumor immune escape mechanism: possible therapeutic implications. J. Transl. Med. 6, 37. doi: 10.1186/1479-5876-6-37
35. Izquierdo-Useros, N., Naranjo-Gómez, M., Archer, J., Hatch, S. C., Erkizia, I., Blanco, J., et al. (2009). Capture and transfer if HIV-1 particles by mature dendritic cells converges with the exosome-dissemination pathway. Blood 113, 2732-2741. doi: 10.1182/blood-2008-05-158642
36. Izquierdo-Useros, N., Naranjo-Gómez, M., Erkizia, I., Puertas, M. C., Borràs, F. E., Blanco, J., et al. (2010). HIV and mature dendritic cells: Trojan exosomes riding the Trojan horse? PLoS Pathog. 6, e1000740. doi: 10.1371/journal.ppat.1000740
37. Janowska-Wieczorek, A., Wysoczynski, M., Kijowski, J., Marquez-Curtis, L., Machalinski, B., Ratajczak, J., et al. (2005). Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int. J. Cancer 113, 752-760. doi: 10.1002/ijc.20657
38. Ji, H., Greening, D. W., Barnes, T. W., Lim, J. W., Tauro, B. J., Rai, A., et al. (2013). Proteome profiling of exosomes derived from human primary and metastatic colorectal cells reveal differential expression of key metastatic factors and signal transduction components. Proteomics 13, 1672-1686. doi: 10.1002/pmic.201200562
39. Johnstone, R. M., Adam, M., Hammond, J. R., Orr, L., and Turbide, C. (1987). Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J. Biol. Chem. 262, 9412-9420.
40. Keller, S., König, A. K., Marmé, F., Runz, S., Wolterink, S., Koensgen, D., et al. (2009). Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes. Cancer Lett. 278, 73-81. doi: 10.1016/j.canlet.2008.12.028
41. Kesimer, M., Scull, M., Brighton, B., DeMaria, G., Burns, K., O'Neal, W., et al. (2009). Characterization of exosome-like vesicles released from human tracheobronchial ciliated epithelium: a possible role in innate defense. FASEB J. 23, 1858-1868. doi: 10.1096/fj.08-119131
42. Kim, J. W., Galanzha, E. I., Zaharoff, D. A., Griffin, R. J., and Zharov, V. P. (2013). Nanotheranostics of circulating tumor cells, infections and other pathological features in vivo. Mol. Pharm. 10, 813-830. doi: 10.1021/mp300577s
43. Koh, W., Sheng, C. T., Tan, B., Lee, Q. Y., Kuznetsov, V., Kiang, L. S., et al. (2010). Analysis of deep sequencing microRNA expression profile from human embryonic stem cells derived mesenchymal stem cells reveals possible role of let-7 microRNA family in downstream targeting of hepatic nuclear factor 4 alpha. BMC Genomics 11(Suppl. 1), S6. doi: 10.1186/1471-2164-11-S1-S6
44. Kucharzewska, P., Christianson, H. C., Welch, J. E., Svensson, K. J., Fredlund, E., Ringnér, M., et al. (2013). Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development. Proc. Natl. Acad. Sci. U.S.A. 110, 7312-7317. doi: 10.1073/pnas.1220998110
45. Lenassi, M., Cagney, G., Liao, M., Vaupotic, T., Bartholomeeusen, K., Cheng, Y., et al. (2010). HIV Nef is secreted in exosomes and triggers apoptosis in bystander CD4+ T cells. Traffic 11, 110-122. doi: 10.1111/j.1600-0854.2009.01006.x
46. Lewis, C. E., and Pollard, J. W. (2006). Distinct role of macrophages in different tumor microenvironments. Cancer Res. 66, 605-612. doi: 10.1158/0008-5472.CAN- 05-4005
47. Liang, B., Peng, P., Chen, S., Li, L., Zhang, M., Cao, D., et al. (2013). Characterization and proteomic analysis of ovarian cancer-derived exosomes. J. Proteomics 80C, 171-182. doi: 10.1016/j.jprot.2012.12.029
48. Manahan, K. J., Taylor, D. D., and Gercel-Taylor, C. (2001). Clonal heterogeneity of p53 mutations in ovarian cancer. Int. J. Oncol. 19, 387-394.
49. Marhaba, R., Klingbeil, P., Nuebel, T., Nazarenko, I., Buechler, M. W., and Zoeller, M. (2008). CD44 and EpCAM: cancer-initiating cell markers. Curr. Mol. Med. 8, 784-804. doi: 10.2174/156652408786733667
50. Mathivanan, S., and Simpson, R. J. (2009). ExoCarta: a compendium of exosomalproteins and RNA. Proteomics 9, 4997-5000. doi: 10.1002/pmic.200900351
51. McLellan, A. D. (2009). Exosome release by primary B cells. Crit. Rev. Immunol. 29, 203-217. doi: 10.1615/CritRevImmunol.v29.i3.20
52. Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., et al. (2008). Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. U.S.A. 105, 10513-10518. doi: 10.1073/pnas.0804549105
53. Mittelbrunn, M., Gutiérrez-Vázquez, C., Villarroya-Beltri, C., González, S., Sánchez-Cabo, F., González, M. Á., et al. (2011). Unidirectional transfer of microRNAloaded exosomes from T cells to antigen-presenting cells. Nat. Commun. 2, 282. doi: 10.1038/ncomms1285
54. Montecalvo, A., Shufesky, W. J., Stolz, D. B., Sullivan, M. G., Wang, Z., Divito, S. J., et al. (2008). Exosomes as a short-range mechanism to spread alloantigen between dendritic cells during T cell allorecognition. J. Immunol. 180, 3081-3090.
55. Nazarenko, I., Rana, S., Baumann, A., McAlear, J., Hellwig, A., Trendelenburg, M., et al. (2010). Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation. Cancer Res. 70, 1668-1678. doi: 10.1158/0008-5472.CAN-09-2470
56. Ostrowski, M., Carmo, N. B., Krumeich, S., Fanget, I., Raposo, G., Savina, A., et al. (2010). Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat. Cell Biol. 12, 19-30. doi: 10.1038/ncb2000
57. Pan, B. T., Blostein, R., and Johnstone, R. M. (1983). Loss of the transferrin receptor during the maturation of sheep reticulocytes in vitro: an immunological approach. Biochem. J. 210, 37-47.
58. Park, J. E., Tan, H. S., Datta, A., Lai, R. C., Zhang, H., Meng, W., et al. (2010). Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes. Mol. Cell Proteomics 9, 1085-1099. doi: 10.1074/mcp. M900381-MCP200
59. Peinado, H., Aleǧkoviǧ, M., Lavotshkin, S., Matei, I., Costa-Silva, B., Moreno-Bueno, G., et al. (2012). Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat. Med. 18, 883-891.
60. Pigati, L., Yaddanapudi, S. C., Iyengar, R., Kim, D. J., Hearn, S. A., Danforth, D., et al. (2010). Selective release of microRNA species from normal and malignant mammary epithelial cells. PLoS ONE 5, e13515. doi: 10.1371/journal.pone.0013515
61. Quah, B. J., and O'Neill, H. C. (2005). Maturation of function in dendritic cells for tolerance and immunity. J. Cell. Mol. Med. 9, 643-654. doi: 10.1111/j.1582-4934.2005.tb00494.x
62. Rabinowits, G., Gercel-Taylor, C., Day, J. M., Taylor, D. D., and Kloecker, G. H. (2009). Exosomal microRNA: a diagnostic marker for lung cancer. Clin. Lung Cancer 10, 42-46. doi: 10.3816/CLC.2009.n.006
63. Rak, J. (2010). Microparticles in cancer. Semin. Thromb. Hemost. 36, 888-906. doi: 10.1055/s-0030-1267043
64. Rana, S., Malinowska, K., and Zöller, M. (2013). Exosomal tumor microRNA modulates premetastatic organ cells. Neoplasia 15, 281-295.
65. Ratajczak, J., Wysoczynski, M., Hayek, F., Janowska-Wieczorek, A., and Ratajczak, M. Z. (2006). Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 20, 1487-1495. doi: 10.1038/sj.leu.2404296
66. Sheldon, H., Heikamp, E., Turley, H., Dragovic, R., Thomas, P., Oon, C. E., et al. (2010). New mechanism for Notch signaling to endothelium at a distance by Deltalike 4 incorporation into exosomes. Blood 116, 2385-2394. doi: 10.1182/blood-2009-08-239228
67. Silva, J., Garcia, V., Rodriguez, M., Compte, M., Cisneros, E., Veguillas, P., et al. (2012). Analysis of exosome release and its prognostic value in human colorectal cancer. Genes Chromosomes Cancer 51, 409-418.
68. Simons, M., and Raposo, G. (2009). Exosomes-vesicular carriers for intercellular communication. Curr. Opin. Cell Biol. 21, 575-581.
69. Skog, J., Wurdinger, T., van Rijn, S., Meijer, D. H., Gainche, L., Sena-Esteves, M., et al. (2008). Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 10, 1470-1476. doi: 10.1038/ncb1800
70. Takeshita, N., Hoshino, I., Mori, M., Akutsu, Y., Hanari, N., Yoneyama, Y., et al. (2013). Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma. Br. J. Cancer 108, 644-652. doi: 10.1038/bjc.2013.8
71. Taylor, D. D., and Black, P. H. (1986). "Shedding of plasma membrane fragments: neoplastic and develpomental importance," in Developmental Biology, Vol. 3, ed M. Steinberg (New York, NY: Plenum Press), 33-57.
72. Taylor, D. D., and Doellgast, G. J. (1979). Quantitation of peroxidase-antibody binding to membrane fragments using column chromatography. Anal. Biochem. 98, 53-59. doi: 10.1016/0003-2697(79)90704-8
73. Taylor, D. D., and Gercel-Taylor, C. (2005). Tumor-derived exosomes as mediates of T-cell signaling defects. Br. J. Cancer 92, 305-311.
74. Taylor, D. D., and Gercel-Taylor, C. (2008). MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol. Oncol. 110, 13-21. doi: 10.1016/j.ygyno.2008.04.033
75. Taylor, D. D., and Gercel-Taylor, C. (2011). Exosomes/Microvesicles: mediators of cancer-associated immunosuppressive microenvironments. Semin. Immunopathol. 33, 441-454. doi: 10.1007/s00281-010-0234-8
76. Taylor, D. D., Gercel-Taylor, C., and Weese, J. L. (1989). Expression and shedding of mdr-1 antigen by variants of the murine B16 melanoma. Surg. Forum 40, 406-408.
77. Taylor, D. D., Homesley, H. D., and Doellgast, G. J. (1980). Binding of specific peroxidase-labeled antibody to placental-type phosphatase on tumor-derived membrane fragments. Cancer Res. 40, 4064-4069.
78. Taylor, D. D., Homesley, H. D., and Doellgast, G. J. (1983). Membrane-associated immunoglobulins in cyst and ascites fluids of ovarian cancer patients. Am. J. Reprod. Immunol. 3, 7-11. doi: 10.1111/j.1600-0897.1983.tb00204.x
79. Taylor, D. D., Levy, E. M., and Black, P. H. (1985). "Shed membrane vesicles: a mechanism for tumor induced immunosuppression," in Immunity to Cancer, eds M. S. Mitchell and A. E. Reif (Ann Arbor, MI: Academic Press), 369-373.
80. Taylor, D. D., Zacharias, W., and Gercel-Taylor, C. (2011). Exosome isolation for proteomic analyses and RNA profiling. Methods Mol. Biol. 728, 235-246. doi: 10.1007/978-1-61779-068-3_15
81. Teng, H., Hu, M., Yuan, L. X., Liu, Y., Guo, X., Zhang, W. J., et al. (2012). Suppression of inflammation by tumor-derived exosomes: a kind of natural liposome packaged with multifunctional proteins. J. Liposome Res. 22, 346-352. doi: 10.3109/08982104.2012.710911
82. Tetta, C., Ghigo, E., Silengo, L., Deregibus, M. C., and Camussi, G. (2013). Extracellular vesicles as an emerging mechanism of cell-to-cell communication. Endocrine doi: 10.1007/s12020-012-9839-0. [Epub ahead of print].
83. Théry, C., Ostrowski, M., and Segura, E. (2009). Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol. 9, 581-593. doi: 10.1038/nri2567
84. Trams, E. G., Lauter, C. J., Salem, C. Jr., and Heine, U. (1981). Exfoliation of membrane ecto-enzymes in the form of microvesicles. Biochim. Biophys. Acta 645, 63-70. doi: 10.1016/0005-2736(81)90512-5
85. Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., and Lötvall, J. O. (2007). Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654-659. doi: 10.1038/ncb1596
86. Valapala, M., and Vishwanatha, J. K. (2011). Lipid raft endocytosis and exosomal transport facilitate extracellular trafficking of annexin A2. J. Biol. Chem. 286, 30911-30925. doi: 10.1074/jbc. M111.271155
87. Viswanathan, M., Sangiliyandi, G., Vinod, S. S., Mohanprasad, B. K., and Shanmugam, G. (2003). Genomic instability and tumor-specific alterations in oral squamous cell carcinomas assessed by inter-(simple sequence repeat) PCR. Clin. Cancer Res. 9, 1057-1062.
88. Whiteside, T. L. (2013). Immune modulation of T-cell and NK (natural killer) cell activities by TEXs (tumour derived exosomes). Biochem. Soc. Trans. 41, 245-251. doi: 10.1042/BST20120265
89. Xiang, X., Poliakov, A., Liu, C., Liu, Y., Deng, Z. B., Wang, J., et al. (2009). Induction of myeloid-derived suppressor cells by tumor exosomes. Int. J. Cancer. 124, 2621-2633. doi: 10.1002/ijc.24249
90. Xiao, D., Ohlendorf, J., Chen, Y., Taylor, D. D., Rai, S. N., Waigel, S., et al. (2012). Identifying mRNA, microRNA and protein profiles of melanoma exosomes. PLoS ONE 7, e46874. doi: 10.1371/journal.pone.0046874
91. Yang, M., Chen, J., Su, F., Yu, B., Su, F., Lin, L., et al. (2011). Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells. Mol. Cancer 10, 117. doi: 10.1186/1476-4598-10-117
92. Yu, X., Harris, S. L., and Levine, A. J. (2006). The regulation of exosome secretion: a novel function of the p53 protein. Cancer Res. 66, 4795-4801. doi: 10.1158/0008-5472.CAN-05-4579
93. Yuan, X. L., Chen, L., Li, M. X., Dong, P., Xue, J., Wang, J., et al. (2010). Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner. Clin. Immunol. 134, 277-288. doi: 10.1016/j.clim.2009.10.005
94. Zhang, Y., Liao, J. M., Zeng, S. X., and Lu, H. (2011). p53 downregulates Down syndrome-associated DYRK1A through miR-1246. EMBO Rep. 12, 811-817. doi: 10.1038/embor.2011.98
95. Zhang, Y., Liu, D., Chen, X., Li, J., Li, L., Bian, Z., et al. (2010). Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol. Cell. 39, 33-144. doi: 10.1016/j.molcel.2010.06.010
96. Zumaquero, E., Muñoz, P., Cobo, M., Lucena, G., Pavón, E. J., Martín, A., et al. (2010). Exosomes from human lymphoblastoid B cells express enzymatically active CD38 that is associated with signaling complexes containing CD81, Hsc-70, and Lyn. Exp. Cell Res. 316, 2692-2706.